Given the significant role of hnRNPA2B1 in exporting CSC‐related mRNAs in breast tumor cells, we hypothesized that targeting hnRNPA2B1 could abrogate chemoresistance in breast tumor. Here, HNRNPA2B1 is linked to breast neoplasm.